According to the study, in which researchers from the Institute of Medical Sciences called up 926 Covaxin recipients and enquired about long-term AESIs after a year of vaccination, viral upper respiratory tract infections were reported by 304 (48%) adolescents and 124 (43%) adults in this period.
1 in 3 Covaxin recipients hit by adverse events: Study
